Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Maria Caterina Cavallo"'
Autor:
Maria Caterina Cavallo, Marianna Cavazza, Francesca Bonifazi, Beatrice Casadei, Ilaria Cutini, Barbara Tonietti, Riccardo Saccardi, PierLuigi Zinzani, Claudio Jommi
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Chimeric antigen receptor T cells (CAR-T) represent an innovation but raise issues for healthcare payers because of the uncertainty on impact at market launch, high cost and important organisational impact. The literature has focu
Externí odkaz:
https://doaj.org/article/882a0c8986bf40a8a3f153eac91177c5
Autor:
Francesco Bamfi, Federica Basso, Massimo Aglietta, Carmelo Bengala, Vito Lorusso, Paolo Pronzato, Maria Caterina Cavallo, Orietta Zaniolo, Sergio Iannazzo
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 10, Iss 1, Pp 33-46 (2009)
Objective: to estimate the impact of lapatinib utilization within the Italian National Health Service (NHS) resources consumption. Lapatinib is an oral inhibitor of kinase protein, approved as dual therapy with capecitabine for the treatment of metas
Externí odkaz:
https://doaj.org/article/dc5376cf7e7a4fc997137dadbb9560a1
Autor:
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 9, Iss 1S, Pp 3-10 (2008)
Introduction: the impact of cervical cancer prevention, in particular through HPV female vaccination, has been published for many countries at the national level. However, to our knowledge no attempt has been made to address the impact at a regional
Externí odkaz:
https://doaj.org/article/13f265baf2fc40a39822058a034e3762
Autor:
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 9, Iss 1S, Pp 51-53 (2008)
In Umbria region 67,5% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 13 cases of cervicocarcinoma
Externí odkaz:
https://doaj.org/article/5e8f74d91703400a8953dced97316056
Autor:
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 9, Iss 1S, Pp 63-65 (2008)
In Abruzzo region 55,4% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 29 cases of cervicocarcinom
Externí odkaz:
https://doaj.org/article/6faf9c36d59444eda4c68a7c84cfbea2
Autor:
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 9, Iss 1S, Pp 55-57 (2008)
In Marche region 65,7% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 26 cases of cervicocarcinoma
Externí odkaz:
https://doaj.org/article/b711787112bb44de97810fd4a470e6e3
Autor:
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 9, Iss 1S, Pp 15-17 (2008)
In Aosta Valley region 77,9% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 2 cases of cervicocarc
Externí odkaz:
https://doaj.org/article/57abfa87adcb438c9bc8ea180f30bd93
Autor:
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 9, Iss 1S, Pp 71-73 (2008)
In Campania region 41,8% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 208 cases of cervicocarcin
Externí odkaz:
https://doaj.org/article/994d4e6c4d964b43a8ee117c734e6c10
Autor:
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 9, Iss 1S, Pp 79-81 (2008)
In Basilicata region 57,5% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 14 cases of cervicocarci
Externí odkaz:
https://doaj.org/article/f63167d776b44a378ae0174814754a18
Autor:
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 9, Iss 1S, Pp 47-49 (2008)
In Tuscany region 70,2% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 51 cases of cervicocarcinom
Externí odkaz:
https://doaj.org/article/bcf8b708ece0480387132a75a76a78f5